Turn Therapeutics (TTRX) Accounts Payables (2024 - 2026)

Turn Therapeutics has reported Accounts Payables for 3 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (changed N/A YoY), and the FY2025 full-year result was $2.9 million, up 338.91% from the prior year.
• Accounts Payables for Q1 2026 stood at $2.3 million, down from $2.9 million in the prior quarter.
• The five-year high for Accounts Payables was $2.9 million in Q4 2025, with the low at $667272.0 in Q4 2024.
• Average Accounts Payables over 3 years is $2.0 million, with a median of $2.3 million recorded in 2025.
• Peak annual rise in Accounts Payables reached 338.91% in 2025, while the deepest fall reached 338.91% in 2025.
• Tracing TTRX's Accounts Payables over 3 years: stood at $667272.0 in 2024, then soared by 338.91% to $2.9 million in 2025, then slipped by 20.95% to $2.3 million in 2026.
• The last three Accounts Payables figures came in at $2.3 million (Q1 2026), $2.9 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison